Charles Schwab Investment Management Inc. Buys New Shares in Bowhead Specialty Holdings Inc. (NYSE:BOW)

Charles Schwab Investment Management Inc. purchased a new position in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW) in the third quarter, HoldingsChannel reports. The fund purchased 65,288 shares of the company’s stock, valued at approximately $1,829,000.

Several other large investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new position in shares of Bowhead Specialty during the second quarter worth $2,770,000. Peregrine Capital Management LLC purchased a new position in shares of Bowhead Specialty during the 2nd quarter valued at about $3,073,000. TD Asset Management Inc acquired a new position in shares of Bowhead Specialty in the 2nd quarter valued at about $265,000. Victory Capital Management Inc. purchased a new stake in shares of Bowhead Specialty in the second quarter worth about $15,973,000. Finally, Emerald Mutual Fund Advisers Trust acquired a new stake in Bowhead Specialty during the second quarter worth about $4,901,000.

Insider Transactions at Bowhead Specialty

In other news, Director Family Mutual Insuran American sold 1,362,285 shares of the business’s stock in a transaction that occurred on Friday, October 25th. The stock was sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the transaction, the director now directly owns 4,700,761 shares in the company, valued at $130,211,079.70. The trade was a 22.47 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. JMP Securities boosted their price target on Bowhead Specialty from $32.00 to $33.00 and gave the company a “market outperform” rating in a report on Wednesday, November 6th. Royal Bank of Canada boosted their target price on shares of Bowhead Specialty from $32.00 to $35.00 and gave the company an “outperform” rating in a research note on Wednesday, November 6th. Keefe, Bruyette & Woods raised their price target on shares of Bowhead Specialty from $35.00 to $36.00 and gave the company a “market perform” rating in a research report on Wednesday, December 4th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Bowhead Specialty from $26.00 to $30.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Bowhead Specialty currently has an average rating of “Hold” and a consensus price target of $32.00.

Bowhead Specialty Stock Performance

NYSE:BOW opened at $36.22 on Tuesday. Bowhead Specialty Holdings Inc. has a fifty-two week low of $22.14 and a fifty-two week high of $37.81. The company has a fifty day moving average of $32.72 and a two-hundred day moving average of $29.34.

Bowhead Specialty (NYSE:BOW) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.38. The firm had revenue of $116.76 million during the quarter, compared to analyst estimates of $113.00 million. As a group, sell-side analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.38 earnings per share for the current year.

Bowhead Specialty Company Profile

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.